|
US2016146812A1
|
|
Method of detecting and identifying circulating antigens in human biological samples
|
|
WO2016040479A1
|
|
N-heterocyclic phosphines
|
|
US2015377935A1
|
|
Signal identification methods and systems
|
|
WO2016007391A1
|
|
Methods and systems for information search
|
|
US2015361371A1
|
|
Hydrothermal carbonization of algal feedstocks and fuels produced thereby
|
|
WO2015161255A1
|
|
Methods for enhancing or decreasing the levels of mir124 and mir29 in subjects with muscular dystrophy
|
|
WO2015153956A1
|
|
Paenibacillus larvae treatment with phage lysin for american foulbrood disease
|
|
WO2015131091A1
|
|
Systems and methods for approximating the soft tissue profile of the skull of an unknown subject
|
|
US2016060401A1
|
|
Fire retardant materials and devices including same
|
|
WO2016026130A1
|
|
Sodium anti-perovskite solid electrolyte compositions
|
|
WO2015017700A2
|
|
Camouflaged communication device
|
|
US2014324835A1
|
|
Methods And Systems For Information Search
|
|
US2014287958A1
|
|
Cantilevered probes having piezoelectric layer, treated section, and resistive heater, and method of use for chemical detection
|
|
WO2014194280A2
|
|
Novel suicidal lsd1 inhibitors targeting sox2-expressing cancer cells
|
|
US2015048526A1
|
|
Functional coatings enhancing condenser performance
|
|
CA2919952A1
|
|
Methods of treating muscular dystrophy
|
|
CN105102688A
|
|
Room temperature electrodeposition of actinides from ionic solutions
|
|
WO2014120643A1
|
|
Use of 3-bromopyruvate as a contraceptive
|
|
US2014213144A1
|
|
Lysing Paenibacillis larvae by exposure to phage
|
|
WO2014040077A1
|
|
Methods of treating muscular dystrophy
|
